AT-1965
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AT-1965, covering 2025-05-02 to 2025-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors [Phase 1, Phase 2]